13 reports

That year, tuberculosis surpassed HIV as the world' s most lethal infection.

  • Ambulatory Care
  • Cancer
  • Obesity
  • Therapy
  • United States

It has also been estimated that the mortality rates due to diabetes is much higher when compared to human immunodeficiency virus infection (HIV) and acquired immune deficiency syndrome (AIDS), malaria, and tuberculosis.

  • Obesity
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.

Jude Medical List of Exhibits ##: Executive Summary Table ##-##: The Global Market for Advanced Patient Monitoring Systems, 2012-2021 ##: Advanced Patient Monitoring Products and Technologies Table ##-##: Clinical Trial Activity by Industry Participant Figure ##-

  • Obesity
  • Patient Monitoring
  • Telemedicine
  • World
  • Forecast
  • MICROBIOME DIAGNOSTICS: DEVELOPMENT PIPELINE

One Way Liver ##.

  • Obesity
  • United States
  • Enterome Bioscience SA
  • MicroBiome Therapeutics LLC
  • Seres Therapeutics, Inc.

## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## P I ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Dis ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Un ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## IND ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## PC ## ## ## ##

  • Obesity
  • Psychotic Disorder
  • United States
  • Company
  • Product Initiative

It undertakes extensive research and development of pharmaceuticals for treatment of migraine, gastrointestinal, psoriasis, central nervous system, cardiovascular, tuberculosis, diabetes and inflammation.

  • Musculoskeletal Disorder
  • Obesity
  • United States
  • Company
  • Product Initiative
  • OBESITY - PIPELINE BY YUYU PHARMA, INC., H2 2016
  • OBESITY - PIPELINE BY XL-PROTEIN GMBH, H2 2016

Its project pipeline includes products with therapeutic application in the area of diabetes type II, leishmaniasis, and tuberculosis.

  • Biotechnology
  • Obesity
  • Type 2 Diabetes
  • Company
  • Product Initiative
  • YUHAN CORP
  • OBESITY - PIPELINE BY XL-PROTEIN GMBH, H1 2017

PHIN-## (PGC GLP-## (GLUCAGON-LIKE PEPTIDE-##)) DELIVERS FULLY ACTIVE NATIVE HUMAN GLP-##.

  • Diabetes
  • Obesity
  • United States
  • Company
  • Product Initiative
  • TYPE2 DIABETES - PIPELINE BY BIOLINGUS AG, H1 2018
  • TYPE2 DIABETES - PIPELINE BY BIOCON LTD, H1 2018

Its project pipeline include oral products with therapeutic application in the area of diabetes type II, leishmaniasis and tuberculosis.

  • Biopharmaceutical
  • Obesity
  • North America
  • United States
  • Company
  • OBESITY - PIPELINE BY XL-PROTEIN GMBH, H2 2017
  • OBESITY - PIPELINE BY YUYU PHARMA INC, H2 2017

NET LLC (INACTIVE) CASIGEN PHARMA LTD CONNEXIOS LIFE SCIENCES PVT LTD DAIICHI SANKYO CO LTD ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ##

  • Diabetes
  • Obesity
  • Pharmaceutical
  • Therapy
  • Omeros Corporation

It offers project pipeline such as products with therapeutic application in the area of diabetes type II, leishmaniasis and tuberculosis.

  • Biopharmaceutical
  • Obesity
  • North America
  • United States
  • Company

Chemokine (C-C Motif) Receptor ## (CCR##) Antagonist ## ## ## ## ## ## ## ## ## Chemokine (C-C Motif) Receptor ## (CCR##) Antagonist ## ## ## ## ## ## ## ## ## Cholesterylester Transfer Protein (CETP) Inhibitor ## ## ## ## ## ## ## ## ## Cyclin-Dependent Kinase ## (CDK

  • Monoclonal Antibody
  • Obesity
  • Research And Development
  • United States
  • Bristol-Myers Squibb Company

JD-## acts as a cannabinoid receptor type ## (CB##) antagonist.

  • Analgesic
  • Obesity
  • Research And Development
  • Therapy
  • Jenrin Discovery, Inc.